Transplant Recipients of All Organs and Their Families, Winter 2000 Published by the National Kidney Foundation, Inc

Total Page:16

File Type:pdf, Size:1020Kb

Transplant Recipients of All Organs and Their Families, Winter 2000 Published by the National Kidney Foundation, Inc Transplant Chronicles Volume 7, Number 3 A publication for transplant recipients of all organs and their families, Winter 2000 published by the National Kidney Foundation, Inc. An Incredible Young Woman A bby VanNortwick’s early The on-base clinic did not children’s hospital in Denver. childhood was fairly typical. She have the facilities or equipment Within a few days of arriving in was an active child, who to treat Abby, so she was Denver, Abby received a heart enjoyed activities such as jump airlifted to Triple Army Medical transplant. The operation was rope and bike riding. Then in Center in Honolulu, Hawaii, successful, and only two 1994 Abby’s dad, an where she stayed for nearly two months later, Abby was on the administration chief in the weeks. slopes learning to ski. She even Marines, was stationed in named her new heart “the Iwakuni, Japan, that Abby’s Bomber,” after the life abruptly changed. downhill skiing technique Suddenly eight-year-old she used to careen down Abby began having severe the Rocky Mountains. chest pains. Her parents initially thought she had a Though she enjoyed stomach virus, but soon skiing, swimming became found she was suffering Abby’s passion. In 1997, from dehydration so that passion led Abby to debilitating that she was Sydney, Australia, for the unable to walk or even World Transplant Games. dress herself. Her parents She competed in the 25- Abby VanNortwick, heart recipient and yard backstroke, 50-yard took her to the health clinic champion swimmer. on base. There, Abby freestyle, 50-yard breast- suffered something doctors stroke and 50-yard back- likened to a heart attack. Tests Unfortunately, Abby’s stroke and won the first-place showed that Abby had viral condition worsened, and gold medal in all four events. At myocarditis, an inflammation of doctors said her only hope for the 1998 U.S. Transplant the heart’s muscular walls. The survival was a new heart. Lack Games in Columbus, Ohio, virus kept the once active of proper facilities and Abby won four more gold young girl confined to a bed, equipment sent Abby to yet medals, one for each event in unable to play or go to school. another medical center, a Continued on page 3 transAction! Transplant Chronicles is a COUNCIL Program of the National Kidney Foundation, Inc., supported by Pharmaceuticals Corporation National Kidney Foundation ✍ editor’s desk Transplant Chronicles Welcome to the last issue of Transplant Chronicles is published by Transplant Chronicles for the 20th the National Kidney Foundation, Inc. Century. Right about now everyone Opinions expressed in this publication do not necessarily represent the position of the National Kidney Foundation, Inc. is gearing up for the holidays and Editor-in-Chief: the new millennium. This time of Beverly Kirkpatrick, LSW year is always very stressful. You Philadelphia, Pennsylvania find yourself overeating, stressed Editors: Ira D. Davis, MD Vanessa Underwood, BS, about finances and forgetting to take Cleveland, Ohio AFAA, ACE Plaistow, New Hampshire Beverly Kirkpatrick care of #1...yourself. We hope you’ll Maurie Ferriter, BS find the articles in this issue on Lakeland, Michigan Jim Warren, MS Janet Karlix, PhD San Francisco, California health, diet and transplant medications to be helpful. Gainesville, Florida Becky Weseman, RD, CNSD, When we are busy, we tend to forget about the Teresa Shafer, RN, LMNT thousands still waiting for an organ transplant. Don’t MSN, CPTC Omaha, Nebraska Ft. Worth, Texas Laurel Williams Todd, RN, MSN forget to keep on your ambassador hat and, during Nancy Spinozzi, RD Omaha, Nebraska the season of giving, let those around you know that Boston, Massachusetts R. Patrick Wood, MD they too can give in the way of organ donation, by Charlie Thomas, CISW, ACSW Houston, Texas Phoenix, Arizona signing an donor card and discussing this decision Editorial Office: with their families National Kidney Foundation, Inc. 30 E. 33rd Street, New York, NY 10016 (800) 622-9010/(212) 889-2210 Have a joyous holiday season and we’ll see you http://www.kidney.org Executive Editor: Editorial Director: T in the next millennium. C Diane Goetz Gigi Politoski Managing Editor: Production Manager: Sara Kosowsky Austin Duffy Beverly Kirkpatrick Design Director: Oumaya Abi-Saab for the Editorial Board Photo credit pages 1 and 2: Jay LaPrete ✏ Sign Me Up... FOR A FREE MEMBERSHIP IN THE TRANSACTION COUNCIL to receive all of the benefits of membership: a membership card and pin; issues of TransAction Council Connection membership update and Transplant Chronicles newsletter; information on transplant athletic programs, a voice in legislative and public policy issues; participation in NKF educational programs and activities. Just fill out the form and mail it to the transAction Council, National Kidney Foundation, 30 East 33rd Street, NY, NY 10016. Name: ______________________________________________________________________________________ Address:____________________________________________________________________________________ City, State, Zip: ____________________________________________________________________________ Phone: ______________________________________ E-Mail: ______________________________________ I I am not interested in joining transAction Council but would like to continue receiving Transplant Chronicles at no charge. ✃ 2 Transplant Chronicles, Vol. 7, No. 3 the award to Abby, whom he called “an incredible An Incredible Young Woman young woman.” Impressed by her work and continued from page 1 commitment to promoting organ donation, Dr. which she competed: The 100-yard freestyle, 50- Pereira offered to host Abby on a trip to Boston yard backstroke, 50-yard breaststroke and 100- to speak to public school students. “Many yard breaststroke. children grow up with a feeling of entitlement,” says Dr. Pereira. “I thought they should listen to Though she is proud of her outstanding someone who was giving back to the performance at both the 1997 World Games and community.” the 1998 U.S. Games and those eight hard- earned medals, Abby says competing was not Today, five years after her transplant, Abby is what excited her most. “I was more excited about still going strong. She swims with the Bangor meeting people who shared my experience,” she Trident Swim Team, and this past summer says. “It was nice to talk to people who conducted her own two-and-a-half-hour private understood what I went through.” practices while the team was on break. She is currently training for the 2000 U.S. Transplant As important as it was for Abby to be able to Games. She even practices with the masters, relate to and share with others who understood who, she says, have an even harder, more her experiences, it was even more intense workout than the youth team. Abby also important for her to talk about plays the violin in her school organ donation with people who orchestra, and for the past hadn’t considered it. To help three years she has entered her spread the word about the cause labrador retriever, Roxie, in a that saved her life, Abby has fitting, showing and obedience written numerous articles competition. published in Guideposts for Kids, Navy Times, Navy News, Rocky With all her accomplish- Mountain News and Trident Times. ments, medals and awards, She’s also shared her story with Abby says the most amazing the teen monthly Girls’ Life, Sports thing that has happened since Illustrated for Kids, The Boston Herald and the the transplant was simply Fox affiliate station in Seattle, Washington. Abby getting her normal life back. She says she’s admits she does enjoy the media attention happiest when reading and spending time with somewhat, however she says it’s not what drives her family. College is still a ways off for this her to do media interviews. “I don’t do it for eighth grader, but Abby already has her sights myself,” she says. “I do it because media set on a career in marine biology. “The Make A attention can change people’s minds about organ Wish Foundation granted my wish to go to donation. The more I talk about it, the more Hawaii and swim with the dolphins, which was a people become aware that they can save lives.” lot of fun,” says Abby. During that trip, another of Abby’s wishes was granted. She got to surprise Abby also gives talks to groups in her the doctors at Triple Army Medical Center in community, including her 4H Club and swim Honolulu and thank them for all they did for her team. At the 1998 U.S. Transplant Games, the and her family. Abby is very grateful for her life American Society of Transplant Physicians and her new start. As she puts it, presented Abby with a special award given to “Transplantation gives you a second chance at transplant athletes who have furthered the cause life. It improves your outlook and changes your of organ donation in their return to health and views.” This 13-year-old has some wise advise for productivity. Dr. Brian Pereira, vice chair of the fellow transplant recipients: “After your division of nephrology, New England Medical transplant, get involved in activities,” she says. Center in Boston, and member of the National “You don’t have to sit around because you’ve had Kidney Foundation board of directors, presented a transplant. Make the most of your second T chance.” C Transplant Chronicles, Vol. 7, No. 3 3 When You Can’t Afford $ Your Medication $ by Charlie Thomas, ACSW, CISW I t’s a frightening scenario: you have just become more common in learned that your insurance won’t cover your many communities. medications any longer. It has been over three Medications that were years since you received your transplant and originally prescribed to Medicare will no longer help with medications someone else are either or perhaps you have insurance, but have donated to a support reached your annual prescription limit.
Recommended publications
  • Investigating Interactions Between Phentermine, Dexfenfluramine, and 5-HT2C Agonists, on Food Intake in the Rat
    Psychopharmacology DOI 10.1007/s00213-014-3829-2 ORIGINAL INVESTIGATION Investigating interactions between phentermine, dexfenfluramine, and 5-HT2C agonists, on food intake in the rat Andrew J. Grottick & Kevin Whelan & Erin K. Sanabria & Dominic P. Behan & Michael Morgan & Carleton Sage Received: 2 October 2014 /Accepted: 20 November 2014 # The Author(s) 2014. This article is published with open access at Springerlink.com Abstract Conclusions Dex-phen synergy in the rat is caused by a Rationale Synergistic or supra-additive interactions between pharmacokinetic interaction, resulting in increased central the anorectics (dex)fenfluramine and phentermine have been concentrations of phentermine. reported previously in the rat and in the clinic. Studies with 5- HT2C antagonists and 5-HT2C knockouts have demonstrated Keywords Synergy . BELVIQ® . Lorcaserin . Isobologram . dexfenfluramine hypophagia in the rodent to be mediated by Fen-phen actions at the 5-HT2C receptor. Given the recent FDA approv- al of the selective 5-HT2C agonist lorcaserin (BELVIQ®) for weight management, we investigated the interaction between Introduction phentermine and 5-HT2C agonists on food intake. Objectives This study aims to confirm dexfenfluramine- Fenfluramine (Pondimin) and dexfenfluramine (Redux) are phentermine (dex-phen) synergy in a rat food intake assay, anorectic agents which act to enhance serotonergic transmission to extend these findings to other 5-HT2C agonists, and to both through inhibition of 5-HT reuptake by the parent com- determine whether pharmacokinetic interactions could ex- pounds, and through their major circulating des-ethylated me- plain synergistic findings with particular drug combinations. tabolite, (dex)norfenfluramine, which is a 5-HT reuptake inhib- Methods Isobolographic analyses were performed in which itor, a 5-HT and noradrenaline releasing agent, and a potent phentermine was paired with either dexfenfluramine, the 5- agonist at postsynaptic 5-HT2 receptors (Curzon et al.
    [Show full text]
  • Educational Commentary – Testing for Amphetamines and Related Compounds
    EDUCATIONAL COMMENTARY – TESTING FOR AMPHETAMINES AND RELATED COMPOUNDS Learning Outcomes Upon completion of this exercise, participants will be able to: • list amphetamine-like compounds that may be detected by immunoassay screening tests for amphetamines. • describe the 3 types of amphetamine immunoassays based on their antibody specificity. • discuss common causes of false-positive results when testing for amphetamines. Correct interpretation of testing results for amphetamines and related compounds is dependent on many factors including an understanding of the nomenclature, structure, and metabolism of these compounds. The class of phenethylamine compounds having varying degrees of sympathomimetic activity include amphetamine, methamphetamine, and many other compounds known by several names including amphetamines (as a group), designer drugs often grouped together as ecstasy [3,4- methylenedioxymethamphetamine (MDMA); 3,4-methylenedioxyamphetamine (MDA), and 3,4- methylenedioxy-N-ethylamphetamine (MDEA)], and sympathomimetic amines including ephedrine, pseudoephedrine, and phenylpropanolamine found in over-the-counter (OTC) medications. Amphetamine, a primary amine, and methamphetamine, a secondary amine, have a stereogenic center and have enantiomers or optical isomers designated d (or +) for dextrorotatory and l (or -) for levorotatory. In general, the d isomers are the more physiologically active compounds, but pharmaceutical preparations may consist of either isomer or a mixture of both isomers. When the mixture contains equal concentrations of the 2 enantiomers, it is known as a racemic mixture. The existence of enantiomers for amphetamines creates analytical and interpretative problems. Immunoassay Screening The primary screening methods for detecting amphetamines are immunoassays. The structural similarity to amphetamine or methamphetamine of the compounds previously mentioned makes it difficult to produce antibodies specific for amphetamine, methamphetamine, or both.
    [Show full text]
  • KHAT Latest Revision: June 11, 2005
    KHAT Latest Revision: June 11, 2005 O CH3 NH2 Cathinone OH CH3 NH2 Cathine N CH3 H3C N 3,6-dimethyl-2,5-diphenylpyrazine (dimer of Cathinone) 1. SYNONYMS CFR: Cathinone Cathine CAS #: Cathinone Hydrochloride: 71031-15-7 Cathine Hydrochloride: 2153-98-2 Cathine Base: 492-39-7 Other Names: Catha edulis Kat Mutsawhari Mutsawari Mdimamadzi Musitate Mirungi Miraa Ol meraa Tumayot Liruti Ikwa Arabian Tea 2. CHEMICAL AND PHYSICAL DATA Khat is used as a stimulant or as a medicine in parts of Africa and the Arabian Peninsula. The plant is thought to have been in cultivation before the coffee plant; historical references date the use of the plant to the fourteenth century. Peter Forsskal, a physician and botanist, collected khat specimens in an expedition organized by the King of Denmark in the eighteenth century. Forsskal assigned the name Catha edulis to the plant. The effects produced by the drug include excitation, hypersensitivity, anorexia, insomnia, euphoria, increased respiration, and hyperthermia. These effects closely parallel the effects of d-amphetamine. Khat is a bush or tree that grows naturally in the humid mountainous regions (elevations of 5000 to 6500 feet) of East and South Africa. The trees can grow naturally to over 60 ft; however, cultivated khat trees are pruned and their height to kept to approximately 16 feet. Khat also grows to a height of 3 feet as a small bush in arid regions. Like opium, the alkaloid content of khat will vary with the soil, climatic conditions, and cultivation. Khat belongs to the genus Catha edulis. It is recognized that the genus consists of only one species; however, the plant exhibits extreme polymorphism.
    [Show full text]
  • Saga of the First Orienteer 6 COF Drops 7 Before Looking Forward to the 1999 Season We Must Reflect 1998 World Cup - Final 8 - 9 on Some Special Events of 1998
    ORIENTEERING CANADA Published by the Canadian Orienteering Federation Box 62052. Convent Glen P.O. Orleans, Ontario, K1C 71-18 E-MAIL [email protected] Tel: (613) 830-1147 FAX: (613) 830-0456 OFFICIAL NEWSLETTER OF THE CANADIAN ORIENTEERING FEDERATION Vol. 27 No. 4 WINTER 1999 ISSN 0227-6658 CONTENTS Editorial Editorial 1 Triple Play for AOA Tour of the COF Home Page 2 - 3 BEST WISH ES TO ALL COF MEMBERS FOR A 1998 Asia Pacific Championships 4- HAPPY, H EALTHY1999 AND AN ENJOYABLE Junior Camp Director 5 SEASON OF ORIENTEERING. Saga of the First Orienteer 6 COF Drops 7 Before looking forward to the 1999 season we must reflect 1998 World Cup - Final 8 - 9 on some special events of 1998. For some, a wonderful World Orienteering Marathon - 1999 10 week of orienteering in British Columbia for the Sage Stomp Orienteering in 2001 World Games Orienteers Assist Firefighters 12 `98 events, in particular the COC events in lovely settings National Team News 13 at Logan Lake. For others, a memorable trip to Whitehorse National Junior Training Camp 14 for the Western Canadian and Yukon Championships. For People on the Move 14 many this was their first visit to the Yukon and from comments Safety Procedures 15-16 received it was wonderful and exceeded their high Ombudsman 16 expectations. If the Yukon association submit an application Good Ideas 17-18 to host a future COC it will be met with great enthusiasm - Words of Wisdom 18 let us hope we don't have to wait too long. Items for Sale 19 Back Cover 20 While 1998 holds many fine memories 1999 promises to be just as exciting with, perhaps, less spectacular scenery and meet sites.
    [Show full text]
  • Preparation of Amphetamines From
    Europäisches Patentamt *EP001442006B1* (19) European Patent Office Office européen des brevets (11) EP 1 442 006 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.7: C07C 209/00 of the grant of the patent: 24.08.2005 Bulletin 2005/34 (86) International application number: PCT/US2002/034400 (21) Application number: 02802245.7 (87) International publication number: (22) Date of filing: 28.10.2002 WO 2003/037843 (08.05.2003 Gazette 2003/19) (54) PREPARATION OF AMPHETAMINES FROM PHENYLPROPANOLAMINES VERFAHREN ZUR HERSTELLUNG VON AMPHETAMINEN AUS PHENYLPROPANOLAMINEN PREPARATION D’AMPHETAMINES A PARTIR DE PHENYLPROPANOLAMINES (84) Designated Contracting States: • REINER LUCKENBACH: "Beilstein Handbuch AT BE BG CH CY CZ DE DK EE ES FI FR GB GR der Organischen Chemie, vol. XII, 4th Ed., 4th IE IT LI LU MC NL PT SE SK TR Suppl., p. 2586 to 2591" 1984 , SPRINGER VERLAG , BERLIN . HEIDELBERG . NEW YORK (30) Priority: 29.10.2001 US 20488 TOKYO XP002235852 page 2586 -page 2591 • HANS-G. BOIT: "Beilsteins Handbuch der (43) Date of publication of application: Organischen Chemie, vol. XII, 4th Ed., Third 04.08.2004 Bulletin 2004/32 Suppl. page 2664 to page 2669" 1973 , SPRINGER VERLAG , BERLIN . HEIDELBERG . (73) Proprietor: Boehringer Ingelheim Chemicals, Inc. NEW YORK XP002235853 page 2664 -page 2669 Peterburg, VA 23805 (US) • DATABASE CROSSFIRE BEILSTEIN [Online] BEILSTEIN INSTITUT ZUR FOEDERUNG DER (72) Inventors: CHEMISCHEN WISSENSCHAFTEN, • BOSWELL, Robert F., FRANKFURT AM MAIN, DE; Boehringer Ingelheim Chem.
    [Show full text]
  • (19) United States (12) Patent Application Publication (10) Pub
    US 20130289061A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2013/0289061 A1 Bhide et al. (43) Pub. Date: Oct. 31, 2013 (54) METHODS AND COMPOSITIONS TO Publication Classi?cation PREVENT ADDICTION (51) Int. Cl. (71) Applicant: The General Hospital Corporation, A61K 31/485 (2006-01) Boston’ MA (Us) A61K 31/4458 (2006.01) (52) U.S. Cl. (72) Inventors: Pradeep G. Bhide; Peabody, MA (US); CPC """"" " A61K31/485 (201301); ‘4161223011? Jmm‘“ Zhu’ Ansm’ MA. (Us); USPC ......... .. 514/282; 514/317; 514/654; 514/618; Thomas J. Spencer; Carhsle; MA (US); 514/279 Joseph Biederman; Brookline; MA (Us) (57) ABSTRACT Disclosed herein is a method of reducing or preventing the development of aversion to a CNS stimulant in a subject (21) App1_ NO_; 13/924,815 comprising; administering a therapeutic amount of the neu rological stimulant and administering an antagonist of the kappa opioid receptor; to thereby reduce or prevent the devel - . opment of aversion to the CNS stimulant in the subject. Also (22) Flled' Jun‘ 24’ 2013 disclosed is a method of reducing or preventing the develop ment of addiction to a CNS stimulant in a subj ect; comprising; _ _ administering the CNS stimulant and administering a mu Related U‘s‘ Apphcatlon Data opioid receptor antagonist to thereby reduce or prevent the (63) Continuation of application NO 13/389,959, ?led on development of addiction to the CNS stimulant in the subject. Apt 27’ 2012’ ?led as application NO_ PCT/US2010/ Also disclosed are pharmaceutical compositions comprising 045486 on Aug' 13 2010' a central nervous system stimulant and an opioid receptor ’ antagonist.
    [Show full text]
  • Reflections on Contagious Off-Label Use of Phentermine and Fenfluramine
    University of Massachusetts Medical School eScholarship@UMMS Population and Quantitative Health Sciences Publications Population and Quantitative Health Sciences 2008 Weighing in 10 Years Later: Reflections on Contagious Off-Label Use of Phentermine and Fenfluramine Regina C. Grebla Brown University Et al. Let us know how access to this document benefits ou.y Follow this and additional works at: https://escholarship.umassmed.edu/qhs_pp Part of the Bioinformatics Commons, Biostatistics Commons, Epidemiology Commons, and the Health Services Research Commons Repository Citation Grebla RC, Waring ME. (2008). Weighing in 10 Years Later: Reflections on Contagious Off-Label Use of Phentermine and Fenfluramine. Population and Quantitative Health Sciences Publications. Retrieved from https://escholarship.umassmed.edu/qhs_pp/379 This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Population and Quantitative Health Sciences Publications by an authorized administrator of eScholarship@UMMS. For more information, please contact [email protected]. Looking Back, Learning Forward History doesn’t repeat itself -- at best it sometimes rhymes. Mark Twain Weighing in 10 years later: Reflections on Contagious off-label use of Phentermine and Fenfluramine Contributed by Regina C. Grebla, MGA, MPH PhD(c) Molly E. Waring AM PhD(c) Graduate students, Brown Medical School The piece for this edition of Scribe focuses on the phentermine and fenfluramine story. This edition comes to you from two students in my advanced pharmacoepidemiology course, shortened significantly to meet the needs of this column. I welcome contributions which stay true to the theme of reflecting and learning about past challenges in pharmacoepidemiology. Please forward ideas to : [email protected] .
    [Show full text]
  • Pharmacology and Toxicology of Amphetamine and Related Designer Drugs
    Pharmacology and Toxicology of Amphetamine and Related Designer Drugs U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES • Public Health Service • Alcohol Drug Abuse and Mental Health Administration Pharmacology and Toxicology of Amphetamine and Related Designer Drugs Editors: Khursheed Asghar, Ph.D. Division of Preclinical Research National Institute on Drug Abuse Errol De Souza, Ph.D. Addiction Research Center National Institute on Drug Abuse NIDA Research Monograph 94 1989 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Alcohol, Drug Abuse, and Mental Health Administration National Institute on Drug Abuse 5600 Fishers Lane Rockville, MD 20857 For sale by the Superintendent of Documents, U.S. Government Printing Office Washington, DC 20402 Pharmacology and Toxicology of Amphetamine and Related Designer Drugs ACKNOWLEDGMENT This monograph is based upon papers and discussion from a technical review on pharmacology and toxicology of amphetamine and related designer drugs that took place on August 2 through 4, 1988, in Bethesda, MD. The review meeting was sponsored by the Biomedical Branch, Division of Preclinical Research, and the Addiction Research Center, National Institute on Drug Abuse. COPYRIGHT STATUS The National Institute on Drug Abuse has obtained permission from the copyright holders to reproduce certain previously published material as noted in the text. Further reproduction of this copyrighted material is permitted only as part of a reprinting of the entire publication or chapter. For any other use, the copyright holder’s permission is required. All other matieral in this volume except quoted passages from copyrighted sources is in the public domain and may be used or reproduced without permission from the Institute or the authors.
    [Show full text]
  • Gymnastics Association of Texas Ceremony of Honors
    Gymnastics Association of Texas Ceremony of Honors Renaissance Austin Hotel Austin, Texas September 1, 2018 2 Order Of Ceremony National Honor Awards…………………….. 5 Judges Honor Awards……………...…….7-9 NCATA Honor Awards………………...11-13 Collegiate Honor Awards………………....14 USAG Gymnastics for All……..…...…..15-17 USAG Acrobatic Gymnastics………...…18-23 USAG Trampoline and Tumbling…...…. .24-27 Service to Youth Award..……………..…..28-29 Texas Gymnastics Heritage Award………30-31 Distinguished Service Awards…………...32-35 Pride of Texas Award……...……………..36-37 Life Member Award..……………………. 38-39 3 4 NATIONAL HONOR AWARDS The Honor Award is presented annually to persons who have brought honor to the State of Texas by their service as leaders of National Organizations, coaching of champions and/or winning of National titles in gymnastics. 5 6 TEXAS GYMNASTICS JUDGES ASSOCIATION HONOR AWARDS WOMEN Mary Atkinson Judged 2018 NAIGC Nationals Marline Blaze Judged USAG NCAA Nationals Marilyn Blilie Judged USAG NCAA Nationals, Melissa Buerher Judged JO Westerns Kandyce Cisne Judged 2018 NAIGC Nationals Denise Coats-Lauriat Judged USAG NCAA Nationals, NHSGA Senior Nationals Janet Cochran Judged 2018 NAIGC Nationals Bonnie Crawford Judged 2018 NAIGC Nationals Chelsea Davis Judged National Elite Qualifier Tammy DeGuzman judged International Elite Competition Sam Dwinnell Judged 2018 NAIGC Nationals Pat Ethredge Judged 2018 NAIGC Nationals Kevin Freeman Judged USAG NCAA Nationals Susan Harrison Judged 2018 NAIGC Nationals Dana Martinez Judged 2018 NAIGC Nationals Kathryn
    [Show full text]
  • Assessment of the Feasibility of Oral Controlled Release in an Exploratory
    DDT • Volume 10, Number 17 • September 2005 REVIEWS Assessment of the feasibility of oral controlled release in an exploratory TODAY DRUG DISCOVERY development setting Reviews • Avinash G.Thombre Controlled release (CR) formulations have generally been considered as follow-ons to conventional immediate release formulations to manage the life cycle of a product. Although significant opportunities exist to use CR as an enabling technology for certain exploratory drug candidates, they have not been fully exploited. However, progress made in assessing CR feasibility based on the physicochemical and biopharmaceutical properties of the drug, together with advances made in understanding the various CR technologies and developing formulations in a fast and efficient manner, have increasingly made it possible to consider CR in an exploratory development setting. Only a few years ago, controlled release (CR) was formulations. First, the market expects once-daily usually restricted to managing product life cycle, dosing, so compounds with a short half-life, which enhancing the proprietary position of marketed require more-frequent dosing, might not be attractive drugs and expanding and consolidating a product to develop. Second, CR can sometimes minimize the franchise. CR technologies were mostly licensed undesirable side-effects related to high and rapidly from small specialized drug-delivery companies. increasing peak plasma levels. In product enhance- Although large pharmaceutical companies main- ment, improved product safety and efficacy, and the tained internal CR formulation development (pri- resulting expansion of market position are primary marily as backup), the focus was on developing the drivers. In ED, CR formulations could represent an next generation of new chemical entities (NCEs).
    [Show full text]
  • Extended Start List 拡張スタートリスト / Liste De Départ Détaillée
    Olympic Stadium Athletics オリンピックスタジアム 陸上競技 / Athlétisme Stade olympique Men's Pole Vault 男子棒高跳 / Saut à la perche - hommes TUE 3 AUG 2021 Final Start Time 19:20 決勝 / Finale Extended Start List 拡張スタートリスト / Liste de départ détaillée WORLD RECORD 6.18 DUPLANTIS Armand SWE Glasgow (GBR) 15 FEB 2020 OLYMPIC RECORD 6.03 BRAZ Thiago BRA Rio de Janeiro (BRA) 15 AUG 2016 NOC World Order Athlete Bib Name Code Date of Birth PB SB Ranking Personal Details General Interest Tokyo 2020 Results 1 2223 KARALIS Emmanouil GRE 20 OCT 1999 5.80 5.75 23 Height: - Making OG debut. Placed 15th at 2019 WCh, 21st in 2017. Placed 5th Qualification, Group A: 4th, 5.75 at 2018 Indoor WCh. Silver at 2021 and 2019 U23 European Ch. Bronze at Youth WCh in 2015. In 2020 he signed for Greek football club Paniliakos, which competed in the 2019/20 Gamma Ethniki [fourth tier]. Set an U18 pole vault world record of 5.54m in 2016, winning gold at the 2016 European Youth Championships in Tbilisi, Georgia. 2 1308 BRAZ Thiago BRA 16 DEC 1993 6.03 5.82 7 Height: - Gold at 2016 OG. Finished 5th at 2019 WCh, 19th in 2015, 14th in 2013. Qualification, Group B: 5th, 5.75 Gold at 2013 South American Ch, silver in 2019. Current OR holder. His wife Ana Paula DE OLIVEIRA has represented BRA in high jump, and won gold at the 2015 South American Championships in Lima, Peru. Became first athlete representing Brazil to win Olympic gold in pole vault when he won in 2016 in Rio.
    [Show full text]
  • Presented to the Graduate Council of the University of North Texas in Partial Fulfillment of the Requirements for the Degree Of
    3-7? CHEMICAL IONIZATION (CI) GC/MS ANALYSIS OF UNDERIVATIZED AMPHETAMINES FOLLOWED BY CHIRAL DERIVATIZATION TO IDENTIFY d AND 1-ISOMERS WITH ION TRAP MASS SPECTROMETRY THESIS Presented to the Graduate Council of the University of North Texas in Partial Fulfillment of the Requirements for the Degree of MASTER OF SCIENCE (Pharmacology) By John A. Tarver B.S.,B.A. May, 1991 Tarver, John A. Chemical Ionization (CI) GC/MS Analysis of Underivatized Amphetamines Followed by Chiral Derivatiza- tion to Identify d and 1-Isomers with Ion Trap Mass Spectro- metry. Master of Science (Biomedical Sciences), May, 1991, 26 pp., 9 figures, bibliography, 20 titles. An efficient two step procedure has been developed using CI GC/MS for analyzing amphetamines and related compounds. The first step allows the analysis of underiv- atized amphetamines with the necessary sensitivity and specificity to give spectral identification, including differentiation between methamphetamine and phentermine. The second step involves preparing a chiral derivative of the extract to identify d and 1-isomeric composition. TABLE OF CONTENTS Page LIST OF ILLUSTRATIONS.......... ... .. .. .......... iv INTRODUCTION .1........................... EXPERIMENTAL MATERIALS ...--- - - - - ----... -....-..... 15 METHODS --------------------.---...... 15 RESULTS AND DISCUSSION ...-..-..................... 17 CONCLUSION - - - - - -- - - - - --- - --- . - . 23 APPENDIX......... ---. -----....-.-. ----.. -........ 24 REFERENCES ----------------------------.. --. ...---.. 28 iii LIST OF ILLUSTRATIONS
    [Show full text]